Agilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Agilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.